China Resources Sanjiu Medical & Pharmaceutical Limited (“CR Sanjiu”) successfully completed its 2013 Phase I Corporate Bond Issuance on May 10th, 2013. The total approved size of the corporate bond was RMB1 billion. The issuance of this 5-year Phase I tranche had a total offer size of RMB500 million including an issuer option to raise coupon rate at the end of the 3rd year and an investor’s put option at the end of the 3rd year. The Phase I tranche was unsecured with a coupon rate of 4.60%. Both the issuer and the bond are AA+-rated. CICC acted as Sole Sponsor and Joint Lead Underwriter.